Dr. Andrew Leuchter, MD
Director of TMS Service
Los Angeles, CA
Dr. Andrew Leuchter, MD is a Director of TMS Service at UCLA Health TMS Center in Los Angeles, California, specializing in Transcranial Magnetic Stimulation (TMS) therapy for Depression, Neuromodulation, Research. Andrew is dedicated to providing patients in the Los Angeles County with access to advanced, FDA-cleared brain stimulation treatments that offer a proven alternative when traditional medications fall short. After earning a medical degree from UCLA David Geffen School of Medicine, Andrew pursued specialized training in psychiatry with a focus on interventional and neuromodulation techniques. This academic background, combined with extensive clinical rotations in treatment-resistant cases, built the foundation for a career dedicated to advancing brain stimulation therapy. Dr. Andrew Leuchter, MD brings 30+ years of psychiatric practice to UCLA Health TMS Center, with a significant portion of that career focused specifically on brain stimulation therapies. This depth of experience means patients benefit from a clinician who has navigated every common scenario in TMS treatment — from optimizing coil placement to managing treatment-resistant cases that require creative protocol adjustments. For Andrew, the practice of interventional psychiatry is fundamentally about restoring hope. Many patients arrive at UCLA Health TMS Center after years of unsuccessful medication trials, and Andrew is committed to offering them a scientifically validated path forward through personalized TMS protocols grounded in the latest clinical evidence. Andrew's clinical focus at UCLA Health TMS Center includes specialized expertise in Depression, Neuromodulation, Research. In treating depression with TMS, the focus is on stimulating the left dorsolateral prefrontal cortex (DLPFC), a brain region consistently found to be underactive in patients with major depressive disorder. By restoring normal activity in this region, TMS helps re-engage the neural circuits responsible for mood regulation, motivation, and cognitive function. Clinical trials demonstrate remission rates of 50-60% in treatment-resistant cases. As a specialist in neuromodulation, the focus extends beyond standard TMS protocols to encompass the full spectrum of brain stimulation technologies. This includes conventional repetitive TMS, deep TMS, theta burst stimulation, and emerging accelerated protocols. This breadth of expertise allows for the selection of the most appropriate stimulation approach for each patient's specific condition and treatment history. At UCLA Health TMS Center, Andrew works with BrainsWay Deep TMS, MagVenture, Magstim — giving patients access to multiple FDA-cleared TMS platforms. This multi-device capability allows for protocol selection tailored to each patient's specific diagnosis and treatment targets. Andrew stays current with evolving treatment protocols, including standard repetitive TMS, theta burst stimulation, and accelerated treatment schedules where appropriate. What patients consistently note about Andrew is the combination of clinical expertise and personal attention. From the initial consultation through the final maintenance session, Andrew ensures each patient understands their treatment plan, knows what to expect, and feels supported throughout their recovery journey at UCLA Health TMS Center. To schedule a consultation with Dr. Andrew Leuchter, MD at UCLA Health TMS Center, contact the clinic directly. Andrew welcomes patients from throughout Los Angeles, California, and the surrounding communities who are ready to explore whether TMS therapy may be the right next step in their mental health treatment journey.